{
  "id": 3087749,
  "title": "Big pharma’s next $10 billion gamble: Ozempic for your brain",
  "url": "https://urgent.news/2026/08/24/big-pharmas-next-10-billion-gamble-ozempic-for-your-brain",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-24T19:00:00.000Z",
  "source": {
    "name": "The Sydney Morning Herald",
    "slug": "the-sydney-morning-herald",
    "url": "https://www.smh.com.au/business/companies/big-pharma-s-next-10-billion-gamble-ozempic-for-your-brain-20260824-p60r1a.html?ref=rss"
  },
  "original_language": "en",
  "account": null,
  "summary": "Could a new class of drugs being used to treat rare neurological disorders allow people to function without sleep?",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Age",
        "title": "Big pharma’s next $10 billion gamble: Ozempic for your brain",
        "url": "https://urgent.news/2026/08/24/big-pharmas-next-10-billion-gamble-ozempic-for-your-brain-3088044",
        "published": "2026-08-24T19:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}